HEALTHJun 15 · 13:07 UTCLE MONDE (EN)

Anti-obesity centers prepare for wave of new patients as two drugs are now covered by French health insurance

Requests for consultations at anti-obesity centers in France have surged as Wegovy and Mounjaro are set to be reimbursed by social security starting June 15 under strict conditions.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

WegovytopicMounjarotopicFrench social securityorganizationanti-obesity centersorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 28 · 10:45 UTC
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
HEALTHMay 28 · 08:06 UTC
France to partially reimburse weight-loss drugs for obesity patients
HEALTHMay 28 · 10:34 UTC
France becomes first EU country to reimburse anti-obesity drugs
HEALTHJun 14 · 09:00 UTC
Want obesity drugs covered by insurance? Telehealth companies have a big say
HEALTHApr 14 · 11:00 UTC
US states drop Medicaid coverage of GLP-1 weight-loss drugs as demand rises
HEALTHJun 11 · 13:21 UTC
STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and more